Aktie A400P5 EVAXION BIOTECH A/S
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Evaxion Biotech A/S

Aktien

A400P5

US29970R2040

EVAX

Markt geschlossen - Nasdaq
Andere Börsenplätze
 22:30:01 05.07.2024 		% 5 Tage % 1. Jan.
3.21 USD +1.90% Intraday Chart für Evaxion Biotech A/S +10.69% -53.19%
03.07. Europäische Aktien, die in den USA als American Depositary Receipts gehandelt werden, tendieren im Mittwochshandel höher MT
27.06. Europäische Aktien, die in den USA als American Depositary Receipts gehandelt werden, steigen am Donnerstag MT

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading
Evaxion Reinforces Milestone Timeline and Provides Shareholder Update
European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading
Evaxion Receives Positive Feedback on Patent Application for AI-Based Novel Cancer Vaccine Target Identification Method
European Equities Traded in the US as American Depositary Receipts Nudge Higher Tuesday Trading
Evaxion Biotech A/S : Securities Purchase Agreement Form 6 K
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading
European Equities Traded in the US as American Depositary Receipts Trend Lower Friday But End Week Higher
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading
Bank Stocks Help Nudge European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading
Evaxion Publishes Data, Showing 67% Objective Response Rate in Metastatic Melanoma for the AI-Designed Personalized Cancer Vaccine EVX-01, in Leading Medical Journal
Evaxion Biotech A/S Announces Publication of Data from Its Phase 1 Dose Escalation Study of Its Lead Personalized Cancer Vaccine, EVX-01
European Equities Traded in the US as American Depositary Receipts Trend Sharply Lower in Tuesday Trading
European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading
European Equities Traded in the US as American Depositary Receipts Fall in Monday Trading
Evaxion Presents Positive and Validating Immune Data from Ongoing Phase 2 Trial with AI-Designed EVX-01 Vaccine at the ASCO Annual Meeting 2024
European Equities Traded in the US as American Depositary Receipts Trend Sharply Lower in Wednesday Trading
Earnings Flash (EVAX) EVAXION BIOTECH Reports Q1 Revenue $51,000
Evaxion Announces Business Update and First Quarter 2024 Financial Results
Evaxion Biotech A/S Reports Earnings Results for the First Quarter Ended March 31, 2024
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A400P5 Aktie
  4. Nachrichten Evaxion Biotech A/S
  5. Andere Sprachen